Magnetic Resonance Fingerprinting: A New Window into Multipl
Now open: Certificate Course in Management of Covid-19 by Govt. Of Gujarat and PlexusMDKnow more...Now open: Certificate Course in Management of Covid-19 by Govt. Of Gujarat and PlexusMDKnow more...
Although conventional MRI is an adequate tool for measuring focal inflammatory lesions in multiple sclerosis (MS), there is currently no validated method for specifically measuring demyelination and neurodegeneration in MS. One of the most important obstacles to developing therapies for progressive MS — and a significant unmet need in MS management — is the lack of specificity of conventional MRI to varying types and severity of tissue pathology in MS.

To that end, Cleveland Clinic’s Mellen Center for Multiple Sclerosis Treatment and Research has collaborated with Case Western Reserve University in the application of a revolutionary technology known as magnetic resonance fingerprinting (MRF) to quantitatively assess brain changes in MS. We recently reported findings from the first study applying MRF in patients with MS. After a brief review of MRF, this article shares key findings from that study and looks ahead to next steps in our group’s exploration of this technology’s compelling potential in MS management...

https://consultqd.clevelandclinic.org/2016/09/magnetic-resonance-fingerprinting-new-window-multiple-sclerosis/
Preview
Like
Comment
Share